The wave of AI is accelerating the transformation of the global pharmaceutical industry. AI startup therapiAI announced today (Feb 9) the completion of a Phase 1 AI Proof of Concept (POC) with Panlabs, a world-class leader in biotechnology. Focusing on
Continue Reading
therapiAI, a leading AI pharmaceutical company, announced today the launch of the world’s first AI Agent dedicated to Antibody-Drug Conjugates (ADCs). This technology significantly compresses the traditional 2-3 year R&D exploration phase. By following the AI Agent’s recommendations, researchers can
Continue Reading
Taiwanese AI drug discovery startup TherapiAI, in collaboration with the Development Center for Biotechnology (DCB), recently hosted the “Empowering with AI Agents: Data Transformation and Pharmaceutical Innovation” industry forum. The event centered on the practical application and implementation of AI
Continue Reading
TherapiAI Partners with 100+ Global Pharma Firms at Tokyo Expo to Launch International Expansion Enhancing R&D Efficiency and Compliance Management for Pharmaceutical Companies with an AI Agent Decision Platform. Deepening Taiwan-Japan Collaboration to Establish the APAC Market as the Infrastructure
Continue Reading
TherapiAI Closes Seed Round to Launch Global AI Drug Discovery Expansion Leveraging AI Agents to Enhance Pharmaceutical Efficiency, Reduce Costs, and Shorten R&D Timelines. Based in Taiwan, Expanding to Japan: Creating a Global Platform for Pharma Digital Transformation. AI drug
Continue Reading
Article Categories
Article Categories
Article Categories
Latest Articles
Follow Us
